Shopping Cart
Remove All
Your shopping cart is currently empty
PROTAC TTK Degrader-2 is a potent threonine tyrosine kinase (TTK) PROTAC degrader, achieving DC50 values of 3.1 nM in COLO-205 cells and 12.4 nM in HCT-116 cells. It demonstrates effective target degradation and anticancer activity in a COLO-205 human colorectal cancer cell xenograft mouse model [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | PROTAC TTK Degrader-2 is a potent threonine tyrosine kinase (TTK) PROTAC degrader, achieving DC50 values of 3.1 nM in COLO-205 cells and 12.4 nM in HCT-116 cells. It demonstrates effective target degradation and anticancer activity in a COLO-205 human colorectal cancer cell xenograft mouse model [1]. |
| In vitro | PROTAC TTK degrader-2 (compound 8j), at concentrations from 0 to 10 μM over 96 hours, inhibits cancer cell proliferation [1]. |
| In vivo | PROTAC TTK degrader-2 (8j) administered intraperitoneally at 10 mg/kg exhibits satisfactory pharmacokinetic profiles [1]. Daily intraperitoneal dosing of 10 or 20 mg/kg for 16 days significantly reduces TTK protein levels and suppresses tumor growth [1]. Pharmacokinetic parameters for PROTAC TTK degrader-2 were established in male SD rats [1]. |
| Molecular Weight | 884.03 |
| Formula | C49H57N9O7 |
| Cas No. | 2953426-48-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.